Biomarker in Tissue Samples From Patients With Ewing Sarcoma
NCT ID: NCT01365949
Last Updated: 2016-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This research trial studies biomarkers in tissue samples from patients with Ewing sarcoma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
NCT01480518
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma
NCT01342783
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
NCT00899990
Study of Tumor Samples From Patients With Ewing Sarcoma
NCT00898053
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To determine the frequency of INI-1 protein loss in Ewing Sarcoma.
OUTLINE: Previously collected tissue samples are analyzed for INI-1 protein loss by IHC and tissue microarray.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microarray analysis
protein analysis
immunohistochemistry staining method
laboratory biomarker analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Ewing sarcoma
* Prepared tissue microarray with Ewing sarcoma samples available
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua D. Schiffman, MD
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COG-AEWS11B1
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2011-02857
Identifier Type: REGISTRY
Identifier Source: secondary_id
AEWS11B1
Identifier Type: OTHER
Identifier Source: secondary_id
AEWS11B1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.